Neuroprotective effects of hypothermia and erythropoietin after perinatal asphyxia in newborn rats

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 26, Issue 15, 2013, Pages 1506-1509

  Spasojevic, Slobodan D ^a,b   Stojanovic, Vesna D ^a,b   Barisic, Nenad A ^a,b   Doronjski, Aleksandra R ^a,b   Zikic, Dragan R ^c   Babovic, Sinisa M ^b  

^a Institute of Child and Youth Health Care of Vojvodina   (Serbia)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c Horticulture and Landscape Architecture   (Serbia)

Author keywords

Animals; Asphyxia; Erythropoietin; Hypothermia; Newborns; Rats

Indexed keywords

ERYTHROPOIETIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HISTOPATHOLOGY; INDUCED HYPOTHERMIA; NERVE INJURY; NEUROPROTECTION; NEWBORN; NONHUMAN; PERINATAL ASPHYXIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RECTUM TEMPERATURE; TEMPERATURE SENSITIVITY; THERAPY EFFECT; TREATMENT RESPONSE;

ANIMALS; ANIMALS, NEWBORN; ASPHYXIA NEONATORUM; BRAIN DISEASES; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; FEMALE; HIPPOCAMPUS; HYPOTHERMIA, INDUCED; NEURONS; NEUROPROTECTIVE AGENTS; PREGNANCY; RATS; RATS, WISTAR;

EID: 84884574376     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.789846     Document Type: Article

References (28)

1. Lawn JECS, Zupan J. Lancet neonatal survival steering team: 4 million neonatal deaths: When? Where? Why? Lancet 2005;365: 891-900.
2. Pierrat VHN, Liska A, Thomas D, et al. Groupe d'Etudes en Epidemiologie Perinatale. Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy: population based study. Arch Dis Child Fetal Neonatal Ed 2005;90:F257-61.
3. Gunn AJ, Thoresen M. Hypothermic neuroprotection. NeuroRx 2006;3:154-69.
4. Gunn AJ, Gluckman PD, Wyatt JS, et al. Selective head cooling after neonatal encephalopathy. Lancet 2005;365:1619-20.
5. Simbruner G, Mittal RA, Rohlmann F, et al. Systemic hypothermia after neonatal encephalopathy: outcomes of neo.nEURO.network RCT. Pediatrics 2010;126:e77.
6. Drury PP, Bennet L, Gunn AJ. Mechanisms of hypothermic neuroprotection. Semin Fetal Neonatal Med 2010;15:287-92.
7. Van Doren Hjohnston M. Advances in neonatal neuroprotection and neuroprotective care. Eur J Paediatr Neurol 2011;15:S133.
8. Kelen D, Robertson NJ. Experimental treatments for hypoxic ischaemic encephalopathy. Early Hum Dev 2010;86:369-77.
9. Ghezzi P, Bernaudinb M, Bianchic R, et al. Erythropoietin: not just about erythropoiesis. Lancet 2010;375:2142.
10. Ohlsson A, Aher SM. Early erythropoietin for preventing red blood cell trans-fusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006;3:CD004863.
11. Gonzalez FF, Ferriero DM. Therapeutics for neonatal brain injury. Pharmacol Ther 2008;120:43-53.
12. McPherson RJ, Juul SE. Erythropoietin for infants with hypoxicischemic encephalopathy. Curr Opin Pediatr 2010;22:139-45.
13. Dell Anna E, Chen Y, et al. Delayed neuronal death following perinatal asphyxia in rat. Exp Brain Res 1997;115:105-15.
14. Engidawork E, Loidl F, Chen Y, et al. Comparison between hypothermia and glutamate antagonism treatments on the immediate outcome of perinatal asphyxia. Exp Brain Res 2001;138: 375-83.
15. Stojanovic V, Vuckovic N, Spasojevic S, et al. The influence of EPO and hypothermia on the kidneys of rats after perinatal asphyxia. Ped Nephrol 2012;27:139-44.
16. Thoresen M, Blomgren R, Leberg EM, et al. Posthypoxic cooling of neonatal rats provides protection against brain injury. Arch Dis Child 1996;74:F3-9.
17. Hobbs C, Thoresen M, Tucker A, et al. Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia. Stroke 2008;39:1307-13.
18. Hlutkin S, Zinchuk V. Effect of melatonin on the blood oxygen transport during hypothermia and rewarming in rats. Adv Med Sci 2008;53:234-9.
19. Givehchian M, Beschorner R, Ehmann C, et al. Neuroprotective effects of erythropoietin during deep hypothermic circulatory arrest. Eur J Cardiothorac Surg 2010;37:662-8.
20. Cariou A, Claessens YE, Pene F, et al. Early high-dose erythropoietin therapy and hypothermia after out-of-hospital cardiac arrest: a matched control study. Resuscitation 2008;76:397-404.
21. Laptook AR, Corbett RJ, Burns DK, Sterett R. A limited interval of delayed modest hypothermia for ischemic brain resuscitation is not beneficial in neonatal swine. Pediatr Res 1999;46:383-9.
22. Sirimanne ES, Blumberg RM, Bossano D. The effect of prolonged modification of cerebral temperature on outcome after hypoxicischemic brain injury in the infant rat. Pediatr Res 1996;39:591-7.
23. Perlman JM. Pathogenesis of hypoxic-ischaemic brain injury. J Perinat 2007;27:S39-46.
24. Fan TJ, Han LH, Cong RS, Liang J. Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai) 2005;37:719-27.
25. Hu BP, Liu CL, Onyang Y, et al. Involvemenment of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cer Blood Flow Met 2000;20:1294-300.
26. Wang X, Zhu C, Wang X, et al. The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin. J Neurochem 2004;91:900-10.
27. McPherson RJ, Demers EJ, Juul SE. Safety of high-dose recombinant erythropoietin in a neonatal rat model. Neonatology 2007; 91:36-43.
28. Aranesp-[Product Informathion]. Thousand Oaks, CA: Angen 2005. Available from: http//www.angen.com/patients/products-aranesp.html [last accessed 6 Jun 2011].